Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose IV dexamethasone vs three-day oral dexamethasone for prevention of pemetrexed-induced skin adverse reactions
TCTR20230111003Phase 2Unknown
- Sponsor
- N/A
- Start
- Dec 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in toxicoderma (cADR), sponsored by N/A. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
toxicoderma (cADR)
Beyond the preview
Go deeper on TCTR20230111003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230111003.